Immatics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immatics and other ETFs, options, and stocks.About IMTX
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics.
IMTX Key Statistics
Stock Snapshot
As of today, Immatics(IMTX) shares are valued at $11.37. The company's market cap stands at 1.52B, with a P/E ratio of -6.26.
On 2026-05-10, Immatics(IMTX) stock traded between a low of $11.08 and a high of $11.49. Shares are currently priced at $11.37, which is +2.6% above the low and -1.0% below the high.
The Immatics(IMTX)'s current trading volume is 372.48K, compared to an average daily volume of 479.56K.
In the last year, Immatics(IMTX) shares hit a 52-week high of $12.41 and a 52-week low of $4.15.
In the last year, Immatics(IMTX) shares hit a 52-week high of $12.41 and a 52-week low of $4.15.
Analyst ratings
100%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.